A study has shown that UK National External Quality Assessment Scheme for Blood Coagulation (UK NEQAS BC) lyophilised plasma samples can be tested on HORIBA UK, Medical’s Yumizen G200 haemostasis instrument, confirming that it is accurate and suitable for use in external quality assessment (EQA) exercises.
The study was undertaken and published by scientists from UK NEQAS BC in a poster presentation at the latest European Congress on Thrombosis and Haemostasis, held in Glasgow. Entitled Evaluation of EQA material on Yumizen G200 coagulation analyser: UK NEQAS for Blood Coagulation study, it tested for PT/INR, APTT, fibrinogen, thrombin time and D-dimer. For each of these coagulation parameters, five aliquots of each of three samples (low, normal and high) were tested. Results were compared with the test-specific medians established by previous UK NEQAS BC EQA surveys.
For all the blood coagulation parameters tested, results obtained on the Yumizen G200 were comparable to the test-specific samples, attaining a coefficient of variation (CV%) range of 1.2– 7.8. This demonstrated the suitability of UK NEQAS BC EQA lyophilised plasma samples for testing on the Yumizen G200.
The Yumizen G200 compact, semi-automated haemostasis instrument, used largely in ‘hot labs’ and as a routine laboratory back-up blood coagulation analyser in the UK, is part of HORIBA Medical’s Yumizen G haemostasis diagnostics range. All analysers in this range are user-friendly, efficient and secure. In combination with specifically developed and optimised ready-to-use reagents, Yumizen G provides a high-quality and cost-effective range of blood coagulation solutions that will fit any laboratory size or requirement.
The Yumizen G200 is a two-channel analyser designed for lower-throughout needs and to enable small laboratories to perform coagulation screening, clotting factor assays and D-dimer tests. Easy to operate, due to its innovative user interface and QC management with master calibration curve meaning no calibration is required, the Yumizen G200 delivers results in 120 seconds. It is also efficient as it is maintenance-free and uses three reference measuring methods (clotting, turbidimetric and chromogenic), giving users the choice of best technique for assessing the complex haemostasis process on a single system.
More information on HORIBA UK, Medical and its products is available online.
The following is a link to the UK NEQAS BC poster:
